The fund sold all its Mylan shares after it emerged that one of its products is in stock at a U.S. prison where death sentences are carried out.» Read More
Eighty-six percent of people buying HealthCare.gov plans had at least three insurance companies to choose from this year.
Technical analyst Todd Gordon sets his eyes on Amgen ahead of earnings.
Former Allergan CEO David Pyott tells a Senate hearing the SEC should investigate the Pershing Square-Valeant alliance.
Technical analyst Todd Gordon looks at Amgen ahead of its earnings report. Explains why the stock could be poised to rally.
GlaxoSmithKline shares jumped 3 percent after the U.K.-listed pharmaceutical giant reported second-quarter earnings per share that were slightly higher than forecast on Wednesday.
States that expanded Medicaid programs saw bigger gains in insured rates, as well as access to doctors and medicines, than other states.
Customers of the largest state-run Obamacare exchange can see price cuts if they move out of their current plans.
The department is expected to grant a 10-year health-care IT pact, at up to $10 billion, to overhaul its electronic health system records.
Allergan chief Brent Saunders says the sale of its generics business would allow the company to double down on its higher margin branded business.
One large pharmacy benefit manager warns that costs from new PCSK9 drugs could reach as high as $150 billion annually.
Shares of Regeneron were down about 3 percent after the FDA approved Regeneron's cholesterol-lowering drug Praluent on Friday.
Biogen shares sank after it lowered its 2015 forecast on slower-than-anticipated growth of its multiple sclerosis blockbuster Tecfidera.
Three-D printing could make life a lot easier and affordable for some, Autodesk's Andreas Bastian says.
The world's first malaria vaccine got a green light on Friday from European drugs regulators.
Federal court officers are seeking a unprecedented sentence of life in prison for a peanut company executive convicted of selling salmonella-tainted food. The Associated Press reports.
HealthCare.gov's boss is urging state insurance regulators to consider factors that could weigh against big price increases.
The Centers for Disease Control and Prevention is warning against a salmonella outbreak linked to frozen tuna products.
Eli Lilly chief John Lechleiter tells CNBC all aspects of health care need to be addressed, including the high costs of Obamacare for many Americans.
A new study suggests the idea that more kids are being diagnosed with autism due to reclassification of the issue, NBC reports.
Ebola briefly returned to the headlines this week with a scare at a hospital in New York, but the deadly virus continues to claim victims in West Africa.
Get the best of CNBC in your inbox